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Background:   Cholangiocarcinoma   (CCA)   is  characterized  by  abundant  cancer-­
associated  fibroblasts  (CAF).  Clinical  data  suggest  an  inverse  correlation  between  
αSMA-­positive  CAF  and  survival  in  CCA.  However,  functional  in  vivo  studies  that  
determine   whether   CAF   promote   or   restrict   CCA   are   lacking.  Objectives:   To  
determine  the  cellular  source  and  functions  of  CAF  in  intrahepatic  CCA  (ICC)   in  
vivo.  Methods   and  Results:   Sleeping   beauty-­mediated   overexpression   of  HA-­
tagged   pT3-­myr-­AKT   and   pT3-­EF1aH-­YapS127A   in   the   liver   resulted   in  
desmoplastic  ICC  with  abundant  αSMA-­positive  CAF  and  significant  upregulation  
of  fibrogenic  genes  Acta2  (34-­fold)  and  Col1a1  (125-­fold).  Expression  of  hepatic  
stellate  cell  (HSC)  markers  Des  and  Lrat  mRNA  was  significantly  increased  in  ICC  
(11-­  and  3-­fold,  respectively).  HSC  origin  of  CAF  was  further  supported  by  tracing  
studies   in   triple   transgenic   mice   expressing   LratCre   and   Cre   reporter   TdTom,  
which   label  >99%  of  HSCs   in   the   liver,   in  combination  with  Col1a1-­GFP,  which  
labels  collagen-­producing  fibroblasts.  92.95±  5.27%  (n=10)  of  CAF  were  TdTom-­
positive,  i.e.  derived  from  LratCre+  HSC.  To  functionally  manipulate  HSC-­derived  
CAF   in   vivo,   we   employed   triple   transgenic   mice   expressing   LratCre,   Cre-­
inducible  iDTR   and  Cre   reporter   TdTom.   By   this   approach,   we   depleted   >90%  
CAF,  as  determined  by  TdTom  fluorescence,  qPCR  for  HSC  markers  Lrat,  Lhx2  
and  Des,  as  well  as  Col1a1,  but  not  portal  fibroblast  marker  Msln.  Short-­term  CAF  
depletion  reduced  fibrosis,  tumor  proliferation,  as  determined  by  Ki67  staining  and  
qPCR  for  mKi67  and  Ccnb1,  and  increased  cell  death  in  ICC.  Conclusion:  Our  
study  suggest  that  the  majority  of  CAF  are  HSC-­derived,  and  HSC-­derived  CAF  
support  the  development  of  ICC  by  promoting  tumor  cell  proliferation  and  survival.  
